NCT01933035View on ClinicalTrials.gov

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Immune ThrombocytopeniaChemotherapy Induced ThrombocytopeniaMyelodysplasiaAplastic Anaemia
Interventions
OTHER

Immune Thrombocytopenics

Full blood count with extended platelet parameters

OTHER

Hypo-proliferative thrombocytopenics

Full blood count with extended platelet parameters

OTHER

Control Population

Full blood count with extended platelet parameters

Trial Locations (1)

10019

Roosevelt Hospital, New York

All Listed Sponsors
lead

Beth Israel Medical Center

OTHER

NCT01933035 - Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias. | Biotech Hunter | Biotech Hunter